| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: The Finnish Ovarian Cancer (FINOVA) study
|
Grénman, Seija
|
|
2006
|
42 |
14 |
p. 2196-2199
4 p.
|
artikel
|
| 2 |
Background to Eusoma guidelines and statements
|
Greco, M.
|
|
2006
|
42 |
14 |
p. 2200-2204
5 p.
|
artikel
|
| 3 |
Calendar
|
|
|
2006
|
42 |
14 |
p. I-II
nvt p.
|
artikel
|
| 4 |
Chewing gum and risk of oesophageal adenocarcinoma: A new hypothesis tested in a population-based study
|
Lagergren, Jesper
|
|
2006
|
42 |
14 |
p. 2359-2362
4 p.
|
artikel
|
| 5 |
Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma
|
Yashiro, Masakazu
|
|
2006
|
42 |
14 |
p. 2397-2403
7 p.
|
artikel
|
| 6 |
Depleted uranium and cancer in Danish Balkan veterans deployed 1992–2001
|
Storm, Hans H.
|
|
2006
|
42 |
14 |
p. 2355-2358
4 p.
|
artikel
|
| 7 |
Diffusivity and distribution of vinblastine in three-dimensional tumour tissue: Experimental and mathematical modelling
|
Modok, Szabolcs
|
|
2006
|
42 |
14 |
p. 2404-2413
10 p.
|
artikel
|
| 8 |
Does sunlight prevent cancer? A systematic review
|
van der Rhee, H.J.
|
|
2006
|
42 |
14 |
p. 2222-2232
11 p.
|
artikel
|
| 9 |
Editorial board
|
|
|
2006
|
42 |
14 |
p. ii-
1 p.
|
artikel
|
| 10 |
EJC NEWS, ISSUE 14, 2006
|
|
|
2006
|
42 |
14 |
p. 2191-2195
5 p.
|
artikel
|
| 11 |
Familial risk for histology-specific bone cancers: An updated study in Sweden
|
Ji, Jianguang
|
|
2006
|
42 |
14 |
p. 2343-2349
7 p.
|
artikel
|
| 12 |
Immunocytochemical localisation of plasma membrane GHRH receptors in human tumours using a novel anti-peptide antibody
|
Schulz, Solveig
|
|
2006
|
42 |
14 |
p. 2390-2396
7 p.
|
artikel
|
| 13 |
Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: Clinical considerations
|
Ferrandina, Gabriella
|
|
2006
|
42 |
14 |
p. 2296-2302
7 p.
|
artikel
|
| 14 |
Incidence of and survival from Wilms’ tumour in adults in Europe: Data from the EUROCARE study
|
Mitry, Emmanuel
|
|
2006
|
42 |
14 |
p. 2363-2368
6 p.
|
artikel
|
| 15 |
Intentional and non-intentional non-adherence to medication amongst breast cancer patients
|
Atkins, Louise
|
|
2006
|
42 |
14 |
p. 2271-2276
6 p.
|
artikel
|
| 16 |
Marine pharmacology in 2003–2004: Anti-tumour and cytotoxic compounds
|
Mayer, Alejandro M.S.
|
|
2006
|
42 |
14 |
p. 2241-2270
30 p.
|
artikel
|
| 17 |
Mutational analysis of the hCDC4 gene in gastric carcinomas
|
Lee, J.W.
|
|
2006
|
42 |
14 |
p. 2369-2373
5 p.
|
artikel
|
| 18 |
Neuroblastoma in Hungary
|
Nyári, Tibor A.
|
|
2006
|
42 |
14 |
p. 2350-2354
5 p.
|
artikel
|
| 19 |
Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis
|
Nosho, Katsuhiko
|
|
2006
|
42 |
14 |
p. 2374-2381
8 p.
|
artikel
|
| 20 |
Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: Results of a phase II study
|
Bollet, Marc A.
|
|
2006
|
42 |
14 |
p. 2286-2295
10 p.
|
artikel
|
| 21 |
Patient-reported assessment of quality care at end of life: Development and validation of Quality Care Questionnaire–End of Life (QCQ–EOL)
|
Yun, Young Ho
|
|
2006
|
42 |
14 |
p. 2310-2317
8 p.
|
artikel
|
| 22 |
Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx®) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas
|
Nielsen, O.S.
|
|
2006
|
42 |
14 |
p. 2303-2309
7 p.
|
artikel
|
| 23 |
Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC–ISG–AGITG)
|
Glabbeke, Martine Van
|
|
2006
|
42 |
14 |
p. 2277-2285
9 p.
|
artikel
|
| 24 |
Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis
|
Pace, Elisabetta
|
|
2006
|
42 |
14 |
p. 2382-2389
8 p.
|
artikel
|
| 25 |
Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours
|
Baruchel, S.
|
|
2006
|
42 |
14 |
p. 2335-2342
8 p.
|
artikel
|
| 26 |
The clinical trail of TRAIL
|
Duiker, E.W.
|
|
2006
|
42 |
14 |
p. 2233-2240
8 p.
|
artikel
|
| 27 |
The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?
|
Lakhani, Sunil R
|
|
2006
|
42 |
14 |
p. 2205-2211
7 p.
|
artikel
|
| 28 |
The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells
|
Albanese, Patricia
|
|
2006
|
42 |
14 |
p. 2326-2334
9 p.
|
artikel
|
| 29 |
Towards a pan-European consensus on the treatment of patients with colorectal liver metastases
|
Van Cutsem, Eric
|
|
2006
|
42 |
14 |
p. 2212-2221
10 p.
|
artikel
|
| 30 |
Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: Phase I clinical trial of three dosing schedules in patients with solid malignancies
|
Sharma, R.A.
|
|
2006
|
42 |
14 |
p. 2318-2325
8 p.
|
artikel
|
Tijdschrift beschrijving